MoneyMasters Podcast 🎙️3/27/25: STOP Buying the Dip. Start DOING THIS Instead

Mike Larson | Editor-in-Chief

Want to know why most traders lose money — and how you can avoid the same fate? In this episode of the MoneyShow MoneyMasters Podcast, I’m joined by Brian Shannon, veteran trader and founder of Alphatrends.net.

With more than three decades in the markets, Brian shares hard-earned lessons, including why risk management is everything, why anchored VWAP can change how you trade, and why “Buy the dip” is often a losing strategy for swing traders.

He also breaks down the tools he trusts, the moving averages that actually work, and why building community and discipline are critical in a volatile market like this one. If you’ve been burned chasing breakouts, stuck holding losers, or just want to understand how the pros think — this is the episode to watch.

Brian will also be speaking at the 2025 MoneyShow Masters Symposium Miami, happening May. 15-17 at the Hyatt Regency Miami. Click here to register.

Roschelle: Why Real Estate is Still a Smart Investment in 2025 (Even with Higher Rates)

Is real estate still worth it in today’s uncertain market? At the 2025 MoneyShow Las Vegas, Mitch Roschelle, principal and chief strategy officer at Madison Ventures+, made a powerful case for why real estate continues to be one of the best long-term investments — and why now may be one of the best entry points we’ve seen in years.

He walks through the two historical drivers of wealth creation, explains how uncertainty drives people away from stocks and into real assets like real estate, and shares his firm’s approach to building attainable housing for outsized returns. Whether you're a landlord, a REIT investor, or new to real estate, this session offers real data, real strategies, and real opportunity.

• Silver: What Experts Had to Say at the Swiss Mining Conference
  👉️ TICKERS: PSLV, SLV
  I’m back behind my desk after participating in the Swiss Mining Institute’s March Conference. While gold may be at the start of a mild near-term correction after becoming overbought, silver is looking less overbought and may hold up, advises Peter Krauth, editor of Silver Stock Investor.

• BMY: A High-Yielding Drug Stock with Great Growth Potential
  👉️ TICKER: BMY
  Bristol-Myers Squibb Co. (BMY) traces its corporate beginnings back to 1887. Today, the company is a leader in developing innovative drugs like Eliquis for stroke prevention and Opdivo for cancer immunotherapy, writes Ben Reynolds, editor of Sure Retirement.